By engineering exosomes to display SST or CCK, researchers aim to improve targeting specificity toward cells expressing SST or CCK receptors, such as neurons or glial cells involved in neurodegenerative or psychiatric diseases. This evidence concerns the gene SST and psychiatric disorder.